Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Generic Pharmaceuticals Contract Manufacturing Market Size - By Drug Type, By Product, By Route of Administration, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
... According to SPER Market Research, the Global Generic Pharmaceuticals Contract Manufacturing Market is estimated to reach USD 121.42 billion by 2032 with a CAGR of 6.04%. The industry's growth is being driven by the advantages ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
... market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the growing ... Read More
-
India Urology Drugs Market, By Drug Class (Anticholinergic/ Antispasmodic Agents, Skeletal Muscle Relaxants, Alpha Blockers, Others), By Type (Original Drugs v/s Generic Drugs), By Application (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary
... Erectile Dysfunction, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Region, Competition Forecast & Opportunities, FY2027 India urology drugs market is anticipated to grow with an estimated CAGR in the forecast years FY2023-FY2027, ... Read More
-
Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)
... Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others) The malaria treatment market is expected to grow from US$ 1,638.27 million in 2021 to ... Read More
-
Indian API Market 2022-2028
... the global API market. Rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs), presence of several medium to large API manufacturers, and increasing focus of government on the development of pharmaceutical manufacturing ... Read More
-
Carbapenem Market Share, Size, Trends, Industry Analysis Report, By Product Type (Meropenem, Doripenem, Imipenem, Tebipenem, And Others); By Sales Channel; By Region; Segment Forecast, 2022 - 2030
... reach USD 5.7 billion by 2030, according to a new study by Polaris Market Research. The report “Carbapenem Market Share, Size, Trends, Industry Analysis Report; By Product Type (Meropenem, Doripenem, Imipenem, Tebipenem, And Others); By ... Read More
-
Pharmaceuticals Industry in India - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... India Pharmaceutical Industry has emerged as greater power amid COVID-19. The growth of the India Pharmaceutical industry is largely supported by the government. The emergence of COVID-19 has led to the health crisis that the ... Read More
-
Norway Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... impact on the pharmaceutical and healthcare industry in Norway. As per the article published in 2020 under the title “The COVID-19 pandemic in Norway and Sweden – threats, trust, and impact on daily life: a ... Read More
-
Global Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... USD 9925.16 Million in the year 2021. Acne Treatment Market growth is primarily driven by factors such as a rapid surge in the young population, rising demand for personal wellness and smooth spotless skin due ... Read More
-
North America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in North ... Read More
-
Asia Pacific Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in Asia ... Read More
-
Europe Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in Europe is ... Read More
-
Middle East & Africa Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market ... Read More
-
South & Central America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 325412
... countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $263,595,616,271 million by 2029. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
UAE Pharmacy Retail Market, By Market Structure (Organized v/s Unorganized), By Product Type (Prescribed Drugs, Over-the-Counter Products, Non-Pharmaceutical Products, Medical Equipment), By Therapeutic Area (Cardiovascular, Anti-Diabetic, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Others), By Drug Type (Generic v/s Patented), By Pharmacy Location (Street/Mall Based v/s Hospital Based), By Region, Competition Forecast & Opportunities, 2027
... v/s Patented), By Pharmacy Location (Street/Mall Based v/s Hospital Based), By Region, Competition Forecast & Opportunities, 2027 The UAE pharmacy retail market is projected to register growth at a robust CAGR during the forecast period, ... Read More
-
UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027
... E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027 The UAE pharmaceutical market is projected to grow at a formidable rate during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare ... Read More
-
Vietnam Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027 Vietnam generic drugs market is projected to witness growth at ... Read More
-
North America Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By
... and Growth Forecast, 2022 – 2028 The North America Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028). Inhalation therapy involves dispersing medications into the ... Read More
-
Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By Regiona
... and Forecast, 2022 – 2028 The Global Inhalation and Nasal Spray Generic Drugs Market size is expected to reach $29.9 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period. ... Read More
-
Europe Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By Country
... Growth Forecast, 2022 - 2028 The Europe Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028). Some nasal sprays, including steroid and antihistamine sprays, are ... Read More
-
Prebiotics for Dietary Supplements Market, by Ingredient Type (Galacto-oligosaccharides (GOS), Fructo-oligosaccharides (FOS), Xylooligosaccharides (XOS), Isomaltooligosaccharides (IMO) and Human milk oligosaccharides (HMO)), by Source (Plant (Including Botanicals) and Animal), by Distribution Channel (B2B (Generic) (Broker and Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ... Read More
-
BRIC Countries (Brazil, Russia, India, China) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the ... Read More
-
Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $112,996.1 million to the global generics industry ... Read More
Research Assistance
